"Non-stick" coating improves stent performance
This article was originally published in Clinica
Preliminary results from the independent European SOPHOS trial show improved clinical outcomes for the BiodivYsio "non-stick" stent over other leading makes, says the stent's UK manufacturer Biocompatibles. The stainless-steel stent is covered with phosphorylcholine, which is designed to prevent restenosis by mimicking the body's own phospholipid layer and disguising the steel from the immune system.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.